Financials

  • Market Capitalization 23.91 M
  • Employee 11
  • Founded 1996
  • CEO N/A
  • Website www.cellectar.com
  • Headquarter Delaware, United States
  • FIGI BBG000G9WFQ5
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.35
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4512
TVRD
Tvardi Therapeutics, Inc. - Common Stock
1.82 USD+0.55%-2.67%-14.15%-49.44%24.28 M USD
4513
GNTA
Genenta Science S.p.A. - American Depositary Shares
1.03 USD+4.04%-14.17%-26.95%-72.68%24.14 M USD
4518
ALGS
Aligos Therapeutics, Inc. - Common stock
6.91 USD-2.26%+7.63%+67.31%-29.42%23.94 M USD
4521
JSPR
Jasper Therapeutics, Inc. - Class A Common Stock
0.70 USD0.00%0.00%+16.67%-74.73%23.29 M USD

Notizie